Why Precision Biologics is betting on tumor-specific neoepitopes to reshape monoclonal antibody cancer therapy

Precision Biologics highlights tumor-specific monoclonal antibodies at Festival of Biologics USA. Discover how neoepitope targeting could reshape cancer therapy.